#VisualAbstract: Benralizumab is noninferior to mepolizumab for treatment of eosinophilic granulomatosis with polyangitis

Mar 01, 2024

ABOUT THE CONTRIBUTORS

MORE ARTICLES BELOW

Physician’s Weekly Daily Brief

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

ADVERTISEMENT
Advertisement
MORE ARTICLES BELOW

Physician’s Weekly Daily Brief

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement